Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Esteban Celis

Showing results (51-60 of 121) with videos related to

Pageof 13
Sort By:
International Journal of Cancer|February 2, 2006
Generation of tumoricidal PAX3 peptide antigen specific cytotoxic T lymphocytesDavid A Rodeberg, Rebecca A Nuss, Sherine F Elsawa, et al.
Cancer Immunology, Immunotherapy : CII|October 13, 2005
Defining MHC class II T helper epitopes for WT1 tumor antigenHiroya Kobayashi, Toshihiro Nagato, Naoko Aoki, et al.
Oncoimmunology|October 10, 2015
An optimized peptide vaccine strategy capable of inducing multivalent CD8<sup>+</sup> T cell responses with potent antitumor effectsHyun-Il Cho, Soo-Hyun Jung, Hyun-Jung Sohn, et al.
Cancer Immunology Research|December 13, 2016
Optimization of Peptide Vaccines to Induce Robust Antitumor CD4 T-cell ResponsesTakumi Kumai, Sujin Lee, Hyun-Il Cho, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 22, 2005
Direct cross-priming by th lymphocytes generates memory cytotoxic T cell responsesRichard Kennedy, Anita H Undale, William C Kieper, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 23, 2004
Identification and characterization of a T-helper peptide from carcinoembryonic antigenMarta Ruiz, Hiroya Kobayashi, Juan José Lasarte, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 15, 2013
Adoptive transfer of Tc1 or Tc17 cells elicits antitumor immunity against established melanoma through distinct mechanismsYu Yu, Hyun-Ii Cho, Dapeng Wang, et al.
Cancer Immunology, Immunotherapy : CII|May 29, 2012
A naturally processed HLA-DR-bound peptide from the IL-9 receptor alpha of HTLV-1-transformed T cells serves as a T helper epitopeHiroya Kobayashi, Takumi Kumai, Satoshi Hayashi, et al.
Journal for Immunotherapy of Cancer|September 22, 2020
Poly-IC enhances the effectiveness of cancer immunotherapy by promoting T cell tumor infiltrationHussein Sultan, Juan Wu, Valentyna I Fesenkova, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 27, 2004
Recognition of adult T-cell leukemia/lymphoma cells by CD4+ helper T lymphocytes specific for human T-cell leukemia virus type I envelope proteinHiroya Kobayashi, Toshihiro Nagato, Mitsuru Yanai, et al.
Pageof 13

Showing results (51-60 of 121) with videos related to

Sort By:
Pageof 13
International Journal of Cancer|February 2, 2006
Generation of tumoricidal PAX3 peptide antigen specific cytotoxic T lymphocytesDavid A Rodeberg, Rebecca A Nuss, Sherine F Elsawa, et al.
Cancer Immunology, Immunotherapy : CII|October 13, 2005
Defining MHC class II T helper epitopes for WT1 tumor antigenHiroya Kobayashi, Toshihiro Nagato, Naoko Aoki, et al.
Oncoimmunology|October 10, 2015
An optimized peptide vaccine strategy capable of inducing multivalent CD8<sup>+</sup> T cell responses with potent antitumor effectsHyun-Il Cho, Soo-Hyun Jung, Hyun-Jung Sohn, et al.
Cancer Immunology Research|December 13, 2016
Optimization of Peptide Vaccines to Induce Robust Antitumor CD4 T-cell ResponsesTakumi Kumai, Sujin Lee, Hyun-Il Cho, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 22, 2005
Direct cross-priming by th lymphocytes generates memory cytotoxic T cell responsesRichard Kennedy, Anita H Undale, William C Kieper, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 23, 2004
Identification and characterization of a T-helper peptide from carcinoembryonic antigenMarta Ruiz, Hiroya Kobayashi, Juan José Lasarte, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 15, 2013
Adoptive transfer of Tc1 or Tc17 cells elicits antitumor immunity against established melanoma through distinct mechanismsYu Yu, Hyun-Ii Cho, Dapeng Wang, et al.
Cancer Immunology, Immunotherapy : CII|May 29, 2012
A naturally processed HLA-DR-bound peptide from the IL-9 receptor alpha of HTLV-1-transformed T cells serves as a T helper epitopeHiroya Kobayashi, Takumi Kumai, Satoshi Hayashi, et al.
Journal for Immunotherapy of Cancer|September 22, 2020
Poly-IC enhances the effectiveness of cancer immunotherapy by promoting T cell tumor infiltrationHussein Sultan, Juan Wu, Valentyna I Fesenkova, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 27, 2004
Recognition of adult T-cell leukemia/lymphoma cells by CD4+ helper T lymphocytes specific for human T-cell leukemia virus type I envelope proteinHiroya Kobayashi, Toshihiro Nagato, Mitsuru Yanai, et al.
Pageof 13